
Fixing Broken Discount Drug Program Helps Most Vulnerable in our Communities
For the past several years, progressive politicians here in the Golden State and around the nation have made it their personal missions to demonize the pharmaceutical industry and the costs of prescription drugs. The politicians do this while betraying absolutely no understanding of the basic economics driving the industry, an industry not devoid of its share of challenges and imperfections, but also one with stunning, life-extending and life-enhancing successes. Unfortunately, the demonizing comes at the expense of jeopardizing continued successes.
This is not to say that the pharmaceutical industry does not need sensible regulatory oversight. It does, and, as with any industry, we shouldn’t hesitate to shine a bright light on and hold the “bad actors” accountable if they take advantage of the people they are to serve.
But sometimes, that “bad actor” is the government itself.
Twenty-five years ago, Congress created the so-called 340B drug discount program. It was a good idea at the time, requiring pharmaceutical companies to provide discounted outpatient drugs to clinics and hospitals in areas that serve the uninsured, underinsured, and… Read More